NCT01241214 - Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis | Biotech Hunter

Enrollment

579

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

ACT-129968

ACT-129968 (Dose 1, Dose 2, or Dose 3) or matching placebo administered orally twice daily

DRUG

ACT-129968

ACT-129968 (Dose 4) \& matching placebo administered orally once daily

DRUG

Cetirizine

Ceterizine administered once daily

DRUG

Placebo

Matching placebo administered twice daily.

Trial Locations (7)

Clinical Investigative Site 7907, Kerrville

Clinical Investigative Site 7903, New Braunfels

Clinical Investigative Site 7901, San Antonio

Clinical Investigative Site 7902, San Antonio

Clinical Investigative Site 7904, San Antonio

Clinical Investigative Site 7906, San Antonio

Clinical Investigative Site 7905, Austin